VRNA | Verona Pharma Plc |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.00 |
Leverage | 65.82% |
Market Cap | $ 29.1B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -153.0m |
Margin | 3777.31% |
Verona Pharma plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company is headquartered in London, the United Kingdom.